Seroprevalence of novel coronavirus disease (COVID-19) in Kobe, Japan
Asako Doi, View ORCID ProfileKentaro Iwata, Hirokazu Kuroda, Toshikazu Hasuike, Seiko Nasu, Aya Kanda, Tomomi Nagao, Hiroaki Nishioka, Keisuke Tomii, Takeshi Morimoto, Yasuki Kihara
doi: https://doi.org/10.1101/2020.04.26.20079822
Asako Doi
1Department of Infection Control, Kobe City Medical Center General Hospital, Chuoku 6500047, Kobe, Hyogo, Japan
2Department of Infectious Diseases, Kobe City Medical Center General Hospital, Chuoku 6500047, Kobe, Hyogo, Japan
3Division of Infectious Diseases Therapeutics, Kobe University Graduate School of Medicine, Chuoku 6500017, Kobe, Hyogo, Japan
MDKentaro Iwata
3Division of Infectious Diseases Therapeutics, Kobe University Graduate School of Medicine, Chuoku 6500017, Kobe, Hyogo, Japan
MD, PhDHirokazu Kuroda
1Department of Infection Control, Kobe City Medical Center General Hospital, Chuoku 6500047, Kobe, Hyogo, Japan
2Department of Infectious Diseases, Kobe City Medical Center General Hospital, Chuoku 6500047, Kobe, Hyogo, Japan
MDToshikazu Hasuike
1Department of Infection Control, Kobe City Medical Center General Hospital, Chuoku 6500047, Kobe, Hyogo, Japan
2Department of Infectious Diseases, Kobe City Medical Center General Hospital, Chuoku 6500047, Kobe, Hyogo, Japan
MDSeiko Nasu
1Department of Infection Control, Kobe City Medical Center General Hospital, Chuoku 6500047, Kobe, Hyogo, Japan
4Department of Laboratory Medicine, Kobe City Medical Center General Hospital, Chuoku 6500047, Kobe, Hyogo, Japan
MTAya Kanda
4Department of Laboratory Medicine, Kobe City Medical Center General Hospital, Chuoku 6500047, Kobe, Hyogo, Japan
MTTomomi Nagao
4Department of Laboratory Medicine, Kobe City Medical Center General Hospital, Chuoku 6500047, Kobe, Hyogo, Japan
MTHiroaki Nishioka
2Department of Infectious Diseases, Kobe City Medical Center General Hospital, Chuoku 6500047, Kobe, Hyogo, Japan
MD, PhDKeisuke Tomii
5Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Chuoku 6500047, Kobe, Hyogo, Japan
MD, PhDTakeshi Morimoto
6Department of Clinical Epidemiology, Hyogo Medical College, Mukogawa 6638501, Nishinomiya, Hyogo, Japan
MD, PhDYasuki Kihara
7Kobe City Medical Center General Hospital, Chuoku 6500047, Kobe, Hyogo, Japan
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
Data is available upon request.
Posted May 05, 2020.
Seroprevalence of novel coronavirus disease (COVID-19) in Kobe, Japan
Asako Doi, Kentaro Iwata, Hirokazu Kuroda, Toshikazu Hasuike, Seiko Nasu, Aya Kanda, Tomomi Nagao, Hiroaki Nishioka, Keisuke Tomii, Takeshi Morimoto, Yasuki Kihara
medRxiv 2020.04.26.20079822; doi: https://doi.org/10.1101/2020.04.26.20079822
Seroprevalence of novel coronavirus disease (COVID-19) in Kobe, Japan
Asako Doi, Kentaro Iwata, Hirokazu Kuroda, Toshikazu Hasuike, Seiko Nasu, Aya Kanda, Tomomi Nagao, Hiroaki Nishioka, Keisuke Tomii, Takeshi Morimoto, Yasuki Kihara
medRxiv 2020.04.26.20079822; doi: https://doi.org/10.1101/2020.04.26.20079822
Subject Area
Subject Areas
- Addiction Medicine (346)
- Allergy and Immunology (666)
- Anesthesia (181)
- Cardiovascular Medicine (2636)
- Dermatology (223)
- Emergency Medicine (398)
- Epidemiology (12206)
- Forensic Medicine (10)
- Gastroenterology (756)
- Genetic and Genomic Medicine (4082)
- Geriatric Medicine (387)
- Health Economics (679)
- Health Informatics (2639)
- Health Policy (1002)
- Hematology (362)
- HIV/AIDS (849)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (433)
- Neurology (3861)
- Nursing (209)
- Nutrition (575)
- Oncology (2017)
- Ophthalmology (584)
- Orthopedics (240)
- Otolaryngology (304)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (472)
- Pediatrics (1113)
- Primary Care Research (450)
- Public and Global Health (6513)
- Radiology and Imaging (1396)
- Respiratory Medicine (871)
- Rheumatology (403)
- Sports Medicine (342)
- Surgery (443)
- Toxicology (52)
- Transplantation (185)
- Urology (165)